Kaitlyn K H Goey
Research Subjects
Kaitlyn K H Goey has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Aimery de Gramont
Hôpital Saint-Antoine, Paris, France
1 shared publication - Axel Hinke
CCRC, Düsseldorf, Germany
1 shared publication - Benoist Chibaudel
Department of Medical Oncology, Franco-British Hospital, Fondation Cognacq-Jay, Levallois-Perret, France
1 shared publication - Cornelis J. A. Punt
Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
1 shared publication - David Fisher
UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology University College London London UK
1 shared publication - Dirk Arnold
Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Paul-Ehrlich-Str. 1, 22763 Hamburg, Germany
1 shared publication
Latest Publications
- 21 March 2022
- Vol. 166
[Supportive treatment and decision-making in a patient with severe anaemia when blood transfusion is not an option].
In severely anaemic patients, blood transfusions remain the standard of care when haemoglobin levels become dangerously low. However, in some situations blood transfusion is not an option. In this clinical lesson, we present a case of a young Jehovah's Witness who developed a life-threatening anaemia due to a gastro-intestinal bleeding. The patient did not want to receive blood products. Although blood transfusions seemed crucial, we successfully treated our patient with only supportive measures. This articles gives an overview of supportive treatment options in severely anaemic patients in the absence of blood transfusions. These measures include monitoring and optimization of hemodynamics, prevention of further blood loss, correction of the haemostatic balance, enhancing haemostasis, improving oxygen delivery and optimizing haematopoiesis.
- 21 March 2022
- Vol. 166
[Supportive treatment and decision-making in a patient with severe anaemia when blood transfusion is not an option].
In severely anaemic patients, blood transfusions remain the standard of care when haemoglobin levels become dangerously low. However, in some situations blood transfusion is not an option. In this clinical lesson, we present a case of a young Jehovah's Witness who developed a life-threatening anaemia due to a gastro-intestinal bleeding. The patient did not want to receive blood products. Although blood transfusions seemed crucial, we successfully treated our patient with only supportive measures. This articles gives an overview of supportive treatment options in severely anaemic patients in the absence of blood transfusions. These measures include monitoring and optimization of hemodynamics, prevention of further blood loss, correction of the haemostatic balance, enhancing haemostasis, improving oxygen delivery and optimizing haematopoiesis.
- 1 September 2021
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 99, 102226
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis
- 1 September 2021
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 99, 102226
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis